Larithrocin
Anti-Infectives




Larithrocin
pack form
Clarithromycin 250 mg -
pack form
Clarithromycin 500 mg -
pack form
500 mg Via -

 

Larithrocin 250  mg tab
Larithrocin 500 mg tab

Indications

Larithrocin is indicated for the treatment of the following infections caused by clarithromycin
susceptible organisms.

       • Bacterial pharyngitis
       • Mild to moderate community-acquired pneumonia
       • Acute bacterial sinusitis (adequately diagnosed)
       • Acute exacerbation of chronic bronchitis
       • Skin and soft tissue infections of mild to moderate severity.
       • In appropriate combination with antibacterial therapeutic regimens and an appropriate ulcer

healing medicinal product fof the eradication of Helicobacter pylori in adult patients with Helicobacter
pylori-associated ulcers.

Consideration should be given to official guidance on the appropriate use of antibacterial agents.
Larithrocin is indicated in adults &children 12 years &older.


Larithrocin 500 mg via

Therapeutic indications
Clarithromycin I.V. is indicated whenever parenteral therapy is required for treatment of sensitive
microorganisms in the following conditions:

  • Upper respiratory tract infections.
  • Lower respiratory tract infections.
  • Skin and soft tissue infections.

Consideration should be given to official guidance on the appropriate use of antibacterial agents.






An error has occurred. This application may no longer respond until reloaded. Reload 🗙